News

Inspire Names Health Tech Leader Brett Kleger as New CEO

ARLINGTON, VA / ACCESSWIRE / June 5, 2024 / Inspire, the world's leading online health community and real-world data platform,…

2 years ago

Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business

REDWOOD CITY, CA / ACCESSWIRE / June 5, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and…

2 years ago

How Focused Giving Can Unlock Billions and Catapult Women’s Wealth

NORTHAMPTON, MA / ACCESSWIRE / June 5, 2024 / CAREBy Mark MuckerheideOriginally published on World Economic Forum.I'll start with a…

2 years ago

1933 Industries Extends Expiry Date of Warrants

VANCOUVER, BC / ACCESSWIRE / June 5, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused…

2 years ago

Rett Syndrome Research Trust Launches Roadmap to Cures to Advance Next-Generation Genetic Medicines into Clinical Trials

Roadmap to Cures is an initiative that seeks to raise $40M over the next four years to advance genetic medicine…

2 years ago

Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate

Financing led by Zimmer Biomet with participation from existing investors Johnson & Johnson Innovation – JJDC, Inc., Gideon Strategic Partners,…

2 years ago

CirrusMD Completes National Roll-out of VA Health Chat, Providing Care Access for over 6.8 Million Veterans

VA Health Chat is now available to Veterans in all 18 VISNs across the U.S.DENVER, June 05, 2024 (GLOBE NEWSWIRE)…

2 years ago

Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024

LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical…

2 years ago

Safety Shot Partners with Prime CSB to Expand Distribution Into New York and New Jersey

The First of Its Kind Beverage Adds Two Key Markets to Distribution as Part of Its Northeast Expansion Plan JUPITER,…

2 years ago

First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical Trial

DNA vaccine proof-of-concept study expected to demonstrate an “mRNA better” platform LAWRENCEVILLE, N.J., June 05, 2024 (GLOBE NEWSWIRE) -- IMUNON,…

2 years ago